Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes back

A. Avan, P. Pacetti, M. Reni, M. Milella, E. Vasile, A. Mambrini, V. Vaccaro, S. Caponi, S. Cereda, G.J. Peters, M. Cantore, E. Giovannetti

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1016-1022
JournalInternational Journal of Cancer
Volume133
Issue number4
DOIs
Publication statusPublished - 2013

Cite this